Concepts (261)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Peripheral Arterial Disease | 13 | 2023 | 267 | 4.210 |
Why?
|
Ischemia | 17 | 2023 | 391 | 4.010 |
Why?
|
Endovascular Procedures | 15 | 2023 | 516 | 3.290 |
Why?
|
Vascular Surgical Procedures | 12 | 2022 | 655 | 2.600 |
Why?
|
Blood Vessel Prosthesis Implantation | 11 | 2022 | 705 | 2.190 |
Why?
|
Vascular System Injuries | 4 | 2021 | 52 | 2.040 |
Why?
|
Stents | 11 | 2020 | 1096 | 1.610 |
Why?
|
Lower Extremity | 7 | 2023 | 299 | 1.430 |
Why?
|
Intestinal Fistula | 3 | 2020 | 44 | 1.400 |
Why?
|
Vascular Fistula | 3 | 2020 | 41 | 1.380 |
Why?
|
Limb Salvage | 13 | 2023 | 162 | 1.350 |
Why?
|
Aortic Diseases | 4 | 2019 | 206 | 1.280 |
Why?
|
Carotid Stenosis | 3 | 2019 | 176 | 1.220 |
Why?
|
Cardiovascular Agents | 2 | 2022 | 128 | 1.170 |
Why?
|
Prosthesis-Related Infections | 4 | 2022 | 232 | 1.160 |
Why?
|
Arteries | 2 | 2017 | 274 | 1.050 |
Why?
|
Subclavian Artery | 2 | 2016 | 80 | 0.920 |
Why?
|
Aortic Aneurysm, Abdominal | 3 | 2019 | 384 | 0.890 |
Why?
|
Sex Distribution | 2 | 2021 | 495 | 0.880 |
Why?
|
Risk Factors | 27 | 2023 | 17523 | 0.780 |
Why?
|
Risk Assessment | 14 | 2022 | 6869 | 0.770 |
Why?
|
Drug-Eluting Stents | 1 | 2022 | 131 | 0.760 |
Why?
|
Iatrogenic Disease | 1 | 2021 | 183 | 0.760 |
Why?
|
Practice Patterns, Physicians' | 4 | 2017 | 1303 | 0.750 |
Why?
|
Angioplasty, Balloon | 4 | 2016 | 183 | 0.720 |
Why?
|
Aorta, Abdominal | 3 | 2019 | 152 | 0.680 |
Why?
|
Vascular Diseases | 1 | 2021 | 246 | 0.680 |
Why?
|
Aorta, Thoracic | 3 | 2018 | 546 | 0.650 |
Why?
|
Chi-Square Distribution | 9 | 2017 | 1323 | 0.650 |
Why?
|
Endarterectomy, Carotid | 1 | 2019 | 121 | 0.640 |
Why?
|
Surgical Procedures, Operative | 1 | 2021 | 383 | 0.630 |
Why?
|
Time Factors | 20 | 2022 | 12926 | 0.610 |
Why?
|
Patient Selection | 5 | 2021 | 2055 | 0.590 |
Why?
|
Blood Vessel Prosthesis | 4 | 2022 | 412 | 0.580 |
Why?
|
Aorta | 3 | 2021 | 692 | 0.570 |
Why?
|
Peripheral Vascular Diseases | 3 | 2024 | 136 | 0.560 |
Why?
|
Femoral Vein | 2 | 2017 | 66 | 0.560 |
Why?
|
Forecasting | 1 | 2019 | 694 | 0.550 |
Why?
|
Registries | 4 | 2020 | 2170 | 0.550 |
Why?
|
Axillary Artery | 1 | 2016 | 33 | 0.550 |
Why?
|
Treatment Outcome | 29 | 2023 | 32848 | 0.540 |
Why?
|
Diabetes Complications | 1 | 2017 | 305 | 0.510 |
Why?
|
Aneurysm, Infected | 2 | 2012 | 32 | 0.510 |
Why?
|
Cause of Death | 1 | 2018 | 752 | 0.510 |
Why?
|
Retrospective Studies | 28 | 2023 | 37905 | 0.510 |
Why?
|
Postoperative Complications | 4 | 2019 | 5542 | 0.500 |
Why?
|
Chronic Disease | 7 | 2023 | 1819 | 0.490 |
Why?
|
Diabetic Foot | 3 | 2024 | 154 | 0.490 |
Why?
|
Health Status Disparities | 1 | 2016 | 291 | 0.460 |
Why?
|
Aneurysm, False | 2 | 2012 | 153 | 0.450 |
Why?
|
Aged | 32 | 2023 | 70117 | 0.440 |
Why?
|
Cardiovascular Infections | 1 | 2012 | 7 | 0.430 |
Why?
|
Vascular Patency | 4 | 2020 | 218 | 0.420 |
Why?
|
Popliteal Vein | 1 | 2011 | 9 | 0.420 |
Why?
|
Thrombophlebitis | 1 | 2012 | 31 | 0.420 |
Why?
|
Gastrointestinal Diseases | 1 | 2017 | 589 | 0.410 |
Why?
|
Male | 37 | 2023 | 123000 | 0.410 |
Why?
|
Humans | 54 | 2024 | 261506 | 0.410 |
Why?
|
Surgical Flaps | 1 | 2018 | 927 | 0.400 |
Why?
|
Diabetes Mellitus | 2 | 2017 | 1054 | 0.390 |
Why?
|
Clinical Trials as Topic | 1 | 2021 | 3719 | 0.390 |
Why?
|
Wound Healing | 5 | 2024 | 815 | 0.380 |
Why?
|
Machine Learning | 2 | 2023 | 319 | 0.360 |
Why?
|
Venous Thrombosis | 3 | 2023 | 384 | 0.360 |
Why?
|
Female | 36 | 2023 | 141928 | 0.360 |
Why?
|
United States | 12 | 2021 | 15433 | 0.350 |
Why?
|
Middle Aged | 27 | 2021 | 86204 | 0.340 |
Why?
|
Atherosclerosis | 2 | 2016 | 935 | 0.340 |
Why?
|
Kaplan-Meier Estimate | 8 | 2016 | 6207 | 0.320 |
Why?
|
Critical Illness | 5 | 2019 | 714 | 0.320 |
Why?
|
Myocardial Infarction | 3 | 2023 | 1374 | 0.310 |
Why?
|
Stroke | 3 | 2016 | 1144 | 0.310 |
Why?
|
Cross Infection | 1 | 2011 | 544 | 0.290 |
Why?
|
Hospital Mortality | 4 | 2019 | 1274 | 0.290 |
Why?
|
Severity of Illness Index | 5 | 2018 | 4320 | 0.280 |
Why?
|
Vascular Grafting | 2 | 2018 | 50 | 0.280 |
Why?
|
Texas | 7 | 2016 | 6311 | 0.280 |
Why?
|
Incidence | 4 | 2021 | 5673 | 0.270 |
Why?
|
Reoperation | 4 | 2022 | 1382 | 0.260 |
Why?
|
Leg | 1 | 2006 | 226 | 0.260 |
Why?
|
Device Removal | 2 | 2021 | 337 | 0.260 |
Why?
|
Sex Factors | 2 | 2021 | 2139 | 0.260 |
Why?
|
Comorbidity | 3 | 2017 | 2352 | 0.240 |
Why?
|
Logistic Models | 6 | 2017 | 3441 | 0.240 |
Why?
|
Multivariate Analysis | 3 | 2017 | 4298 | 0.230 |
Why?
|
Arterial Occlusive Diseases | 1 | 2023 | 160 | 0.220 |
Why?
|
Proportional Hazards Models | 4 | 2014 | 4988 | 0.220 |
Why?
|
Angioplasty | 2 | 2014 | 94 | 0.210 |
Why?
|
Odds Ratio | 4 | 2017 | 2316 | 0.210 |
Why?
|
Leg Ulcer | 1 | 2021 | 24 | 0.200 |
Why?
|
Renal Artery Obstruction | 2 | 2012 | 38 | 0.200 |
Why?
|
Decision Support Techniques | 2 | 2019 | 622 | 0.200 |
Why?
|
Patient Advocacy | 1 | 2021 | 92 | 0.200 |
Why?
|
Coinfection | 1 | 2022 | 189 | 0.180 |
Why?
|
Frail Elderly | 1 | 2020 | 118 | 0.180 |
Why?
|
Survival Rate | 5 | 2020 | 12221 | 0.180 |
Why?
|
History, 21st Century | 1 | 2021 | 441 | 0.170 |
Why?
|
Iliac Artery | 1 | 2019 | 108 | 0.170 |
Why?
|
Acute Disease | 2 | 2023 | 2422 | 0.170 |
Why?
|
Retreatment | 2 | 2019 | 452 | 0.170 |
Why?
|
Artificial Intelligence | 1 | 2023 | 388 | 0.170 |
Why?
|
Geriatric Assessment | 1 | 2020 | 275 | 0.170 |
Why?
|
Wearable Electronic Devices | 1 | 2020 | 105 | 0.170 |
Why?
|
Methicillin-Resistant Staphylococcus aureus | 1 | 2022 | 308 | 0.170 |
Why?
|
Quality of Life | 2 | 2023 | 4532 | 0.160 |
Why?
|
Frailty | 1 | 2020 | 113 | 0.160 |
Why?
|
Delivery of Health Care, Integrated | 1 | 2020 | 164 | 0.160 |
Why?
|
Thoracic Injuries | 1 | 2018 | 58 | 0.160 |
Why?
|
Wound Infection | 1 | 2018 | 54 | 0.160 |
Why?
|
Wounds, Penetrating | 1 | 2018 | 89 | 0.160 |
Why?
|
Ankle Joint | 1 | 2017 | 33 | 0.160 |
Why?
|
Abdominal Injuries | 1 | 2018 | 80 | 0.150 |
Why?
|
Healthcare Disparities | 1 | 2023 | 598 | 0.150 |
Why?
|
Monitoring, Physiologic | 1 | 2020 | 502 | 0.150 |
Why?
|
Patient-Centered Care | 1 | 2020 | 294 | 0.150 |
Why?
|
Glasgow Coma Scale | 1 | 2017 | 215 | 0.150 |
Why?
|
Vena Cava, Inferior | 1 | 2018 | 190 | 0.150 |
Why?
|
Laparotomy | 1 | 2018 | 211 | 0.150 |
Why?
|
Thrombosis | 1 | 2023 | 781 | 0.150 |
Why?
|
Injury Severity Score | 1 | 2017 | 237 | 0.140 |
Why?
|
Kidney Transplantation | 1 | 2023 | 755 | 0.140 |
Why?
|
Wounds, Nonpenetrating | 1 | 2018 | 176 | 0.140 |
Why?
|
Video Games | 1 | 2017 | 93 | 0.140 |
Why?
|
Patient Reported Outcome Measures | 1 | 2022 | 799 | 0.140 |
Why?
|
Length of Stay | 2 | 2020 | 1900 | 0.140 |
Why?
|
Angiography, Digital Subtraction | 1 | 2016 | 76 | 0.140 |
Why?
|
Patient Participation | 1 | 2020 | 446 | 0.140 |
Why?
|
Surgical Mesh | 1 | 2018 | 209 | 0.140 |
Why?
|
Recurrence | 2 | 2016 | 4758 | 0.140 |
Why?
|
Exercise Therapy | 1 | 2017 | 288 | 0.130 |
Why?
|
Paclitaxel | 1 | 2022 | 1996 | 0.130 |
Why?
|
Cohort Studies | 3 | 2022 | 9244 | 0.130 |
Why?
|
Aged, 80 and over | 10 | 2021 | 29902 | 0.130 |
Why?
|
Health Knowledge, Attitudes, Practice | 2 | 2020 | 1209 | 0.120 |
Why?
|
Follow-Up Studies | 3 | 2020 | 14889 | 0.120 |
Why?
|
Caregivers | 1 | 2020 | 677 | 0.120 |
Why?
|
Computed Tomography Angiography | 1 | 2016 | 234 | 0.120 |
Why?
|
Anti-Infective Agents | 1 | 2018 | 446 | 0.120 |
Why?
|
Prevalence | 1 | 2021 | 3260 | 0.120 |
Why?
|
Attitude of Health Personnel | 1 | 2020 | 918 | 0.120 |
Why?
|
Pain | 1 | 2022 | 1658 | 0.110 |
Why?
|
Triplets | 1 | 2013 | 10 | 0.110 |
Why?
|
Life Style | 1 | 2016 | 612 | 0.110 |
Why?
|
Prognosis | 2 | 2023 | 21713 | 0.110 |
Why?
|
Kidney | 2 | 2012 | 2146 | 0.110 |
Why?
|
Embolization, Therapeutic | 1 | 2017 | 551 | 0.110 |
Why?
|
Aneurysm | 1 | 2013 | 94 | 0.110 |
Why?
|
Hypoglycemic Agents | 1 | 2016 | 586 | 0.110 |
Why?
|
Thrombectomy | 2 | 2023 | 158 | 0.110 |
Why?
|
Hypertension, Renovascular | 1 | 2011 | 22 | 0.100 |
Why?
|
Blood Glucose | 1 | 2016 | 1244 | 0.100 |
Why?
|
Radiology, Interventional | 1 | 2013 | 138 | 0.100 |
Why?
|
Disease-Free Survival | 2 | 2014 | 10001 | 0.100 |
Why?
|
Adult | 11 | 2021 | 77950 | 0.100 |
Why?
|
Tuberous Sclerosis | 1 | 2013 | 136 | 0.100 |
Why?
|
Databases as Topic | 1 | 2011 | 133 | 0.100 |
Why?
|
Carotid Artery Diseases | 1 | 2013 | 196 | 0.100 |
Why?
|
Education, Medical, Continuing | 1 | 2013 | 251 | 0.100 |
Why?
|
Endoleak | 1 | 2010 | 17 | 0.100 |
Why?
|
Radiography, Interventional | 1 | 2013 | 305 | 0.100 |
Why?
|
Georgia | 1 | 2010 | 53 | 0.100 |
Why?
|
Blood Pressure | 3 | 2011 | 1467 | 0.090 |
Why?
|
Muscle, Skeletal | 1 | 2017 | 1270 | 0.090 |
Why?
|
Iliac Vein | 1 | 2010 | 38 | 0.090 |
Why?
|
Databases, Factual | 1 | 2017 | 2218 | 0.090 |
Why?
|
Leukocytosis | 1 | 2010 | 112 | 0.090 |
Why?
|
Ulcer | 1 | 2010 | 78 | 0.090 |
Why?
|
Bicycling | 1 | 2010 | 38 | 0.090 |
Why?
|
Aortic Rupture | 1 | 2010 | 113 | 0.090 |
Why?
|
Health Care Costs | 1 | 2014 | 674 | 0.090 |
Why?
|
Cross-Sectional Studies | 1 | 2019 | 4314 | 0.090 |
Why?
|
Hematoma | 1 | 2010 | 160 | 0.080 |
Why?
|
Elective Surgical Procedures | 1 | 2010 | 250 | 0.080 |
Why?
|
Percutaneous Coronary Intervention | 1 | 2014 | 342 | 0.080 |
Why?
|
Leukocyte Count | 1 | 2010 | 684 | 0.080 |
Why?
|
Infant | 4 | 2018 | 13310 | 0.080 |
Why?
|
Guideline Adherence | 1 | 2013 | 636 | 0.080 |
Why?
|
Patient Care Team | 1 | 2014 | 795 | 0.080 |
Why?
|
Radiation Dosage | 1 | 2013 | 1014 | 0.080 |
Why?
|
Intraoperative Complications | 1 | 2010 | 301 | 0.080 |
Why?
|
Renal Insufficiency | 1 | 2011 | 321 | 0.080 |
Why?
|
Anesthesia | 1 | 2011 | 296 | 0.080 |
Why?
|
Child, Preschool | 4 | 2018 | 16273 | 0.080 |
Why?
|
Age Factors | 1 | 2017 | 5377 | 0.080 |
Why?
|
Smoking Cessation | 1 | 2013 | 712 | 0.080 |
Why?
|
Smoking | 1 | 2016 | 2440 | 0.080 |
Why?
|
Hypertension | 3 | 2011 | 1503 | 0.070 |
Why?
|
Recovery of Function | 2 | 2011 | 703 | 0.070 |
Why?
|
Graft Survival | 1 | 2010 | 1062 | 0.070 |
Why?
|
Survival Analysis | 1 | 2018 | 9180 | 0.070 |
Why?
|
Child | 5 | 2023 | 29154 | 0.070 |
Why?
|
Femoral Artery | 1 | 2006 | 210 | 0.060 |
Why?
|
Adolescent | 5 | 2018 | 31252 | 0.060 |
Why?
|
Platelet Aggregation Inhibitors | 2 | 2022 | 444 | 0.060 |
Why?
|
Aortic Aneurysm, Thoracic | 1 | 2010 | 595 | 0.060 |
Why?
|
Foot | 1 | 2024 | 104 | 0.060 |
Why?
|
Kidney Diseases | 1 | 2009 | 691 | 0.060 |
Why?
|
Activities of Daily Living | 1 | 2006 | 552 | 0.060 |
Why?
|
Tomography, X-Ray Computed | 4 | 2013 | 7551 | 0.060 |
Why?
|
Renal Veins | 1 | 2023 | 56 | 0.060 |
Why?
|
Practice Guidelines as Topic | 1 | 2013 | 2403 | 0.060 |
Why?
|
Suction | 1 | 2023 | 104 | 0.050 |
Why?
|
Combined Modality Therapy | 1 | 2014 | 8865 | 0.050 |
Why?
|
Rivaroxaban | 1 | 2022 | 59 | 0.050 |
Why?
|
Genetic Variation | 1 | 2009 | 2086 | 0.050 |
Why?
|
Clinical Competence | 3 | 2014 | 1270 | 0.050 |
Why?
|
Organ Size | 2 | 2012 | 690 | 0.050 |
Why?
|
Benchmarking | 1 | 2021 | 273 | 0.040 |
Why?
|
Creatinine | 2 | 2012 | 531 | 0.040 |
Why?
|
Professional-Patient Relations | 1 | 2020 | 124 | 0.040 |
Why?
|
Checkpoint Kinase 2 | 2 | 2009 | 126 | 0.040 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2009 | 1362 | 0.040 |
Why?
|
Young Adult | 5 | 2018 | 21445 | 0.040 |
Why?
|
Aspirin | 1 | 2022 | 455 | 0.040 |
Why?
|
Prospective Studies | 3 | 2023 | 12873 | 0.040 |
Why?
|
Health Services Research | 1 | 2020 | 233 | 0.040 |
Why?
|
Glomerular Filtration Rate | 2 | 2012 | 602 | 0.040 |
Why?
|
Biofeedback, Psychology | 1 | 2017 | 49 | 0.040 |
Why?
|
Qualitative Research | 1 | 2020 | 556 | 0.040 |
Why?
|
Hemorrhage | 1 | 2022 | 712 | 0.040 |
Why?
|
Healthy Volunteers | 1 | 2017 | 187 | 0.040 |
Why?
|
Range of Motion, Articular | 1 | 2017 | 144 | 0.040 |
Why?
|
Electromyography | 1 | 2017 | 226 | 0.040 |
Why?
|
Predictive Value of Tests | 2 | 2019 | 4892 | 0.040 |
Why?
|
Regional Blood Flow | 1 | 2017 | 276 | 0.040 |
Why?
|
Ultrasonography, Doppler | 1 | 2017 | 231 | 0.040 |
Why?
|
Biomechanical Phenomena | 1 | 2017 | 338 | 0.040 |
Why?
|
Blood Flow Velocity | 1 | 2017 | 475 | 0.030 |
Why?
|
Patient Education as Topic | 1 | 2020 | 748 | 0.030 |
Why?
|
Clinical Decision-Making | 1 | 2019 | 524 | 0.030 |
Why?
|
Societies, Medical | 1 | 2021 | 1335 | 0.030 |
Why?
|
Patient Satisfaction | 1 | 2020 | 915 | 0.030 |
Why?
|
Patient Readmission | 1 | 2018 | 548 | 0.030 |
Why?
|
Communication | 1 | 2020 | 876 | 0.030 |
Why?
|
Genetic Predisposition to Disease | 3 | 2013 | 5539 | 0.030 |
Why?
|
Saphenous Vein | 1 | 2013 | 95 | 0.030 |
Why?
|
Feasibility Studies | 1 | 2017 | 2292 | 0.030 |
Why?
|
Fluoroscopy | 1 | 2013 | 232 | 0.030 |
Why?
|
Operating Rooms | 1 | 2013 | 122 | 0.030 |
Why?
|
Pandemics | 1 | 2021 | 1559 | 0.030 |
Why?
|
Angina Pectoris | 1 | 2011 | 80 | 0.030 |
Why?
|
Pilot Projects | 1 | 2017 | 2803 | 0.020 |
Why?
|
Fatal Outcome | 1 | 2013 | 829 | 0.020 |
Why?
|
Renal Replacement Therapy | 1 | 2012 | 135 | 0.020 |
Why?
|
Workload | 1 | 2011 | 198 | 0.020 |
Why?
|
Emergencies | 1 | 2011 | 202 | 0.020 |
Why?
|
Phlebography | 1 | 2010 | 76 | 0.020 |
Why?
|
Biomarkers | 2 | 2012 | 5047 | 0.020 |
Why?
|
Constriction, Pathologic | 1 | 2010 | 310 | 0.020 |
Why?
|
Antihypertensive Agents | 1 | 2011 | 395 | 0.020 |
Why?
|
Pedigree | 1 | 2013 | 1890 | 0.020 |
Why?
|
Thrombolytic Therapy | 1 | 2010 | 257 | 0.020 |
Why?
|
Patient Safety | 1 | 2013 | 649 | 0.020 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2009 | 4549 | 0.020 |
Why?
|
Fibrinolytic Agents | 1 | 2010 | 324 | 0.020 |
Why?
|
Radiation Injuries | 1 | 2013 | 1411 | 0.020 |
Why?
|
Risk | 1 | 2009 | 1972 | 0.020 |
Why?
|
Phenotype | 1 | 2013 | 6295 | 0.010 |
Why?
|
DNA Damage | 1 | 2009 | 1954 | 0.010 |
Why?
|
Heart Failure | 1 | 2011 | 2516 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2012 | 7702 | 0.010 |
Why?
|